In the September 21 issue of Science, Jocelin Kaiser reports that a good deal of interest was generated in the late 1970s that regular uptake of a low dose of aspirin prevents the occurrence of intestinal tumors. However in the next 40 years or so, the enthusiasm to block colon cancer with aspirin declined. Again within the last two years a series of studies were made in the UK in which the effectiveness of low doses of aspirin was confirmed from placebo-controlled clinical trials. Furthermore, concerned researchers say that there are strong indications that regular uptake of low dosage of this painkiller acts as a defense also against the occurrence of other types of cancer.
The purpose of posting this piece of news is to remind GNOBB members and their well wishers not to lose sight of the good effect of aspirin as a prophylactic against colon cancer. “An apple a day keeps the doctor away” need to be supplemented with another: “An aspirin a day keeps the cancer away.”